We are live on ! Find out more
PGEN icon

Precigen
PGEN

130 hedge funds and large institutions have $95.9M invested in Precigen in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

773% more call options, than puts

Call options by funds: $777K | Put options by funds: $89K

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

11% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 38

7% more capital invested

Capital invested by funds: $89.7M → $95.9M (+$6.21M)

0% more funds holding

Funds holding: 130 → 130 (0)

0.81% less ownership

Funds ownership: 24.87% → 24.06% (-0.81%)

Holders
130
Holders Change
–
Holders Change %
0%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
42
Reduced
38
Closed
13
Calls
$777K
Puts
$89K
Net Calls
+$688K
Net Calls Change
+$214K

Top Buyers

Rank Fund Capital Flow
1
PCM
Patient Capital Management
Maryland
+$1.05M
2
GC
GMT Capital
Georgia
+$971K
3
LA
LexAurum Advisors
Kansas
+$221K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$206K
5
Renaissance Technologies
Renaissance Technologies
New York
+$189K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.78M
2
OM
Opaleye Management
Massachusetts
-$1.37M
3
JP Morgan Chase
JP Morgan Chase
New York
-$314K
4
GCP
GSA Capital Partners
United Kingdom
-$213K
5
SMH
Sanders Morris Harris
Texas
-$211K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Patient Capital Management
Maryland
$28.7M +$1.05M +721,203 +4%
BlackRock
2
BlackRock
New York
$16.2M -$169K -116,070 -1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$10.7M -$12.9K -8,874 -0.1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$4.89M +$95.5K +65,794 +2%
State Street
5
State Street
Massachusetts
$4.49M +$25.2K +17,361 +0.6%
IAM
6
Iridian Asset Management
Connecticut
$3.27M -$32.1K -22,129 -1%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$2.73M -$81.2K -55,944 -3%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.87M +$189K +130,500 +12%
Charles Schwab
9
Charles Schwab
California
$1.73M +$39K +26,856 +3%
JP Morgan Chase
10
JP Morgan Chase
New York
$1.7M -$314K -215,915 -17%
Northern Trust
11
Northern Trust
Illinois
$1.63M -$74.1K -51,001 -5%
Morgan Stanley
12
Morgan Stanley
New York
$1.59M -$81.4K -56,024 -5%
GC
13
GMT Capital
Georgia
$1.06M +$971K +668,830 New
SMH
14
Sanders Morris Harris
Texas
$884K -$211K -145,500 -21%
N
15
Nuveen
North Carolina
$845K – – –
EL
16
EMFO LLC
Florida
$821K – – –
CAM
17
ClariVest Asset Management
California
$778K +$20K +13,752 +3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$666K +$28K +19,301 +5%
Citadel Advisors
19
Citadel Advisors
Florida
$663K +$149K +102,500 +32%
Osaic Holdings
20
Osaic Holdings
Arizona
$645K +$159K +109,686 +37%
MP
21
MSD Partners
New York
$561K – – –
Goldman Sachs
22
Goldman Sachs
New York
$529K +$73.3K +50,489 +18%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$432K +$25.5K +17,536 +7%
Cetera Investment Advisers
24
Cetera Investment Advisers
Illinois
$423K +$10.6K +7,300 +3%
LA
25
LexAurum Advisors
Kansas
$381K +$221K +152,023 +170%
1
2 3 4 5

PGEN Hedge Fund Activity: Q2 2024 in Review

130 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q2 2024, worth a combined $95.9M — up 6.9% from $89.7M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PGEN positions and 13 closed out — a net gain of 3 holders — while 42 added to existing stakes and 38 trimmed.

The largest buyer was Patient Capital Management, adding an estimated $1.05M. The largest seller was Millennium Management, cutting an estimated $1.78M.

  • 130 institutional investors held Precigen (PGEN) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $95.9M of Precigen stock for Q2 2024, up 6.9% quarter-over-quarter.
  • 16 funds opened new Precigen positions in Q2 2024 and 13 closed out, a net change of +3 holders.
  • The largest Precigen buyer in Q2 2024 was Patient Capital Management, an estimated $1.05M added.
  • The largest Precigen seller in Q2 2024 was Millennium Management, an estimated $1.78M sold.

Based on aggregated 13F filings for Q2 2024.